Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).

Clinical trial NCT05720130 · RECRUITING

Trial details

NCT number: NCT05720130
Sponsor: AdvanCell Pty Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-resistant Prostate Cancer Metastatic Hormone Sensitive Prostate Cancer

Start date: 2023-03-15
Primary completion: 2029-01-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.